Becker's Healthcare February 22, 2022
Even as COVID-19 cases decline nationally, supply chain disruptions related to the pandemic are still hurting ASC’s ability to function.
Here are six ASC leaders’ thoughts on the state of the supply chain:
Amar Setty, MD. CEO of Premier (Baltimore): The fragile supply chain for pharmaceuticals led to frequent and unpredictable drug shortages for years. COVID-19-related supply shocks have been equally profound — from syringes, needles and fluids, disposables, oxygen, etc. Shortages are leading to price increases. We are dealing with delays, cancellations and a lot of stress. The administration could do more to stimulate supply through policies to increase supplies.
Joe Peluso. Administrator of Aestique Surgery Center in Greensburg, Pa.: Unlike past crises, CMS is restoring the Medicare...